BioDelivery Sciences Acquires U.S. Commercial Rights to Symproic®
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/23/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
- One killed, three injured when man attacks Swedish school with sword
BioDelivery Sciences (BDSI) Commences Underwritten Public Offering of Common Stock
April 10, 2019 4:08 PM EDTBioDelivery Sciences International, Inc. (Nasdaq: BDSI) today announced that it is commencing an underwritten public offering of shares of common stock. In addition, the underwriters will have a 30-day option to purchase from a selling stockholder up to an additional 15% of the shares of common stock offered in the public offering at the public offering price less the underwriting... More
